← All organizations

Highest phase reached
Phase 2
First clinical trial
Mar 16, 2018Last known activity
Apr 6, 2018
Acquired by UCB on Jun 5, 2020
Timeline
2010s
- Jun 1, 2017
Engage Therapeutics Inc.— Founded
2020s
- Jun 5, 2020
UCB— Acquired By
Drugs by trial phase (1 distinct, 2 trials)
Phase 2 (1 own, 0 via acquisition)
Indications
Recent trials (3)
- NCT03516305Lead sponsorPhase 1Apr 6, 2018
- NCT03478982Study chairPhase 2Mar 16, 2018
- NCT03478982Lead sponsorPhase 2Mar 16, 2018
Details
- Founded
- Summit, NJ, US Jun 1, 2017
- Last known activity
- Apr 6, 2018